| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | dacarbazine | CTRPv2 | pan-cancer | AAC | 0.14 | 2e-05 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | 0.2 | 3e-05 |
| mRNA | austocystin d | CTRPv2 | pan-cancer | AAC | 0.15 | 8e-05 |
| mRNA | Bosutinib | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0001 |
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0002 |
| mRNA | Fumonisin B1 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0003 |
| mRNA | PLX4720 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0003 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0005 |
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | 0.17 | 0.0006 |
| mRNA | leptomycin B | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0008 |